A Labasse

794 total citations
21 papers, 665 citations indexed

About

A Labasse is a scholar working on Rheumatology, Pharmacology and Physiology. According to data from OpenAlex, A Labasse has authored 21 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 8 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in A Labasse's work include Osteoarthritis Treatment and Mechanisms (11 papers), Inflammatory mediators and NSAID effects (7 papers) and Cell Adhesion Molecules Research (3 papers). A Labasse is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (11 papers), Inflammatory mediators and NSAID effects (7 papers) and Cell Adhesion Molecules Research (3 papers). A Labasse collaborates with scholars based in Belgium, France and Switzerland. A Labasse's co-authors include Yves Henrotin, SX Zheng, J.-Y. Reginster, Michelle Deberg, Jean-Michel Crielaard, Jean‐Yves Reginster, Donat De Groote, Y Tsouderos, Paul A. Cloos and Brigitte Zegels and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Mineral Research and Annals of the Rheumatic Diseases.

In The Last Decade

A Labasse

21 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Labasse Belgium 12 436 227 134 101 79 21 665
Kimberly K. Brown United States 8 326 0.7× 148 0.7× 122 0.9× 98 1.0× 64 0.8× 9 507
Eric Lejeune Belgium 4 590 1.4× 378 1.7× 149 1.1× 171 1.7× 46 0.6× 4 902
G. Verbruggen Belgium 11 343 0.8× 125 0.6× 96 0.7× 90 0.9× 48 0.6× 26 521
C Bassleer Belgium 11 437 1.0× 210 0.9× 118 0.9× 74 0.7× 37 0.5× 22 619
Marcello Del Carlo United States 7 511 1.2× 226 1.0× 244 1.8× 103 1.0× 80 1.0× 8 848
M A Alvarez-Soria Spain 9 354 0.8× 288 1.3× 181 1.4× 55 0.5× 68 0.9× 11 631
S Macháček Czechia 3 606 1.4× 323 1.4× 79 0.6× 188 1.9× 35 0.4× 5 720
S. Glasson Switzerland 3 436 1.0× 118 0.5× 190 1.4× 144 1.4× 33 0.4× 5 627
C Curtis United Kingdom 7 238 0.5× 113 0.5× 127 0.9× 78 0.8× 58 0.7× 13 535
H. Al-Mussawir United States 8 333 0.8× 240 1.1× 226 1.7× 52 0.5× 74 0.9× 9 660

Countries citing papers authored by A Labasse

Since Specialization
Citations

This map shows the geographic impact of A Labasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Labasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Labasse more than expected).

Fields of papers citing papers by A Labasse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Labasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Labasse. The network helps show where A Labasse may publish in the future.

Co-authorship network of co-authors of A Labasse

This figure shows the co-authorship network connecting the top 25 collaborators of A Labasse. A scholar is included among the top collaborators of A Labasse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Labasse. A Labasse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Labasse, A, et al.. (2021). Identification of new biomarkers for sarcopenia and characterization of cathepsin D biomarker. SHILAP Revista de lepidopterología. 4(2). 122–132. 12 indexed citations
2.
Henrotin, Yves, et al.. (2019). Identification and characterization of new biochemical markers for sarcopenia. Osteoarthritis and Cartilage. 27. S101–S101. 1 indexed citations
3.
4.
5.
Henrotin, Yves, A Labasse, Thierry Franck, et al.. (2013). Collagen catabolism through Coll2-1 and Coll2-1NO2 and myeloperoxidase activity in marathon runners. SpringerPlus. 2(1). 92–92. 10 indexed citations
6.
Ameye, Lieveke, Michelle Deberg, Manuel Oliveira, et al.. (2007). The chemical biomarkers C2C, Coll2‐1, and Coll2‐1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Arthritis & Rheumatism. 56(10). 3336–3346. 28 indexed citations
7.
Deberg, Michelle, et al.. (2007). One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement. Annals of the Rheumatic Diseases. 67(2). 168–174. 53 indexed citations
8.
Deberg, Michelle, A Labasse, Stephan Christgau, et al.. (2005). New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis and Cartilage. 13(3). 258–265. 124 indexed citations
9.
Deberg, M.A., A Labasse, J. Collette, et al.. (2005). One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. Osteoarthritis and Cartilage. 13(12). 1059–1065. 51 indexed citations
10.
Henrotin, Yves, et al.. (2004). Dietary supplementation with chondroitin sulfate and glucosamine HCL does not slow down articular cartilage erosion in biglycan/fibromodulin deficient mice. Open Repository and Bibliography (University of Liège). 1 indexed citations
11.
Deberg, Michelle, A Labasse, Stephan Christgau, et al.. (2003). Cartilage degradation and oxidative damage in osteoarthritic and rheumatoid arthritic patients. Open Repository and Bibliography (University of Liège). 2 indexed citations
12.
Henrotin, Yves, A Labasse, SX Zheng, et al.. (2001). Strontium Ranelate Increases Cartilage Matrix Formation. Journal of Bone and Mineral Research. 16(2). 299–308. 104 indexed citations
13.
Henrotin, Yves, et al.. (2000). Modulation of human chondrocyte metabolism by recombinant human interferon. Osteoarthritis and Cartilage. 8(6). 474–482. 28 indexed citations
14.
Mouithys‐Mickalad, Ange, G. Deby‐Dupont, C. Deby, et al.. (2000). study of the antioxidant properties of nimesulide and 4-OH nimesulide: effects on HRP- and luminol-dependent chemiluminescence produced by human chondrocytes. Osteoarthritis and Cartilage. 8(6). 419–425. 18 indexed citations
15.
Henrotin, Yves, A Labasse, P Simonis, et al.. (1999). Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro.. PubMed. 17(2). 151–60. 26 indexed citations
16.
Henrotin, Yves, A Labasse, P. Deloffre, Y Tsouderos, & Jean‐Yves Reginster. (1998). Regulation of the chondrocyte metabolism by a new divalent strontium salt (S12911). Open Repository and Bibliography (University of Liège). 1 indexed citations
17.
Henrotin, Yves, et al.. (1998). Nitric oxide downregulates interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes.. PubMed. 25(8). 1595–601. 48 indexed citations
18.
Henrotin, Yves, A Labasse, Jean-Marie Jaspar, et al.. (1998). Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes. Clinical Rheumatology. 17(1). 31–39. 73 indexed citations
19.
Henrotin, Yves, et al.. (1996). Effects of three avocado/soybean unsaponifiable mixtures on human chondrocytes metabolism. Open Repository and Bibliography (University of Liège). 3 indexed citations
20.
Henrotin, Yves, et al.. (1996). Effects of exogenous IL-1β, TNFα, IL-6, IL-8 and LIF on cytokine production by human articular chondrocytes. Osteoarthritis and Cartilage. 4(3). 163–173. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly K. Brown Breakdown of academic impact, for papers by Eric Lejeune Breakdown of academic impact, for papers by G. Verbruggen Breakdown of academic impact, for papers by C Bassleer Breakdown of academic impact, for papers by Marcello Del Carlo Breakdown of academic impact, for papers by M A Alvarez-Soria Breakdown of academic impact, for papers by S Macháček Breakdown of academic impact, for papers by S. Glasson Breakdown of academic impact, for papers by C Curtis Breakdown of academic impact, for papers by H. Al-Mussawir
Rankless by CCL
2026